Cargando…

B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition

BACKGROUND: As a negative co-stimulatory molecule of the B7 family, B7-H4 has recently attracted increased attention. However, the clinical value of B7-H4 in colorectal cancer (CRC) remains controversial and requires further investigation. This study aimed to investigate the role of B7-H4 in the cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Xiaotian, Hong, Bo, Feng, Jie, Jin, Yuanqing, Chen, Mengting, Li, Fugang, Qian, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549643/
https://www.ncbi.nlm.nih.gov/pubmed/36217128
http://dx.doi.org/10.1186/s12885-022-10159-5
_version_ 1784805717501280256
author Yan, Xiaotian
Hong, Bo
Feng, Jie
Jin, Yuanqing
Chen, Mengting
Li, Fugang
Qian, Yun
author_facet Yan, Xiaotian
Hong, Bo
Feng, Jie
Jin, Yuanqing
Chen, Mengting
Li, Fugang
Qian, Yun
author_sort Yan, Xiaotian
collection PubMed
description BACKGROUND: As a negative co-stimulatory molecule of the B7 family, B7-H4 has recently attracted increased attention. However, the clinical value of B7-H4 in colorectal cancer (CRC) remains controversial and requires further investigation. This study aimed to investigate the role of B7-H4 in the clinical diagnosis and survival prognosis of CRC. METHODS: The relationships between B7-H4 expression, immune cell infiltration, epithelial-mesenchymal transition (EMT), clinicopathological features, and survival prognosis were determined through the TCGA database and verified in a large CRC cohort (n = 1118). RESULTS: The results showed the level of B7-H4 mRNA expression was significantly increased in the CRC tumor tissues compared with normal tissues (P <  0.001). Immunohistochemistry showed that B7-H4 protein expression was also up-regulated in CRC. The positive rate of B7-H4 in CRC tumor tissues was 76.38%, which was significantly higher than that in non-tumor tissues (P <  0.001). Overexpression of B7-H4 was positively correlated with lymph node metastasis, advanced TNM stage, and poor tumor differentiation (P = 0.012; 0.009; 0.014). Prognostic analysis showed high B7-H4 expression was associated with significantly shorter OS. Multivariate analysis demonstrated the risk of death in CRC patients with high B7-H4 expression is 1.487 times that of low B7-H4 expression. In addition, B7-H4 expression was negatively correlated with the epithelial marker E-cadherin (P <  0.001) and positively correlated with the mesenchymal marker vimentin (P <  0.001) in CRC tissues. However, B7-H4 expression was not associated with the immunosuppressive microenvironment in CRC. CONCLUSION: B7-H4 may represent a potential biomarker for the diagnosis and prognosis of CRC and enhance CRC invasion by promoting EMT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10159-5.
format Online
Article
Text
id pubmed-9549643
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95496432022-10-11 B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition Yan, Xiaotian Hong, Bo Feng, Jie Jin, Yuanqing Chen, Mengting Li, Fugang Qian, Yun BMC Cancer Research BACKGROUND: As a negative co-stimulatory molecule of the B7 family, B7-H4 has recently attracted increased attention. However, the clinical value of B7-H4 in colorectal cancer (CRC) remains controversial and requires further investigation. This study aimed to investigate the role of B7-H4 in the clinical diagnosis and survival prognosis of CRC. METHODS: The relationships between B7-H4 expression, immune cell infiltration, epithelial-mesenchymal transition (EMT), clinicopathological features, and survival prognosis were determined through the TCGA database and verified in a large CRC cohort (n = 1118). RESULTS: The results showed the level of B7-H4 mRNA expression was significantly increased in the CRC tumor tissues compared with normal tissues (P <  0.001). Immunohistochemistry showed that B7-H4 protein expression was also up-regulated in CRC. The positive rate of B7-H4 in CRC tumor tissues was 76.38%, which was significantly higher than that in non-tumor tissues (P <  0.001). Overexpression of B7-H4 was positively correlated with lymph node metastasis, advanced TNM stage, and poor tumor differentiation (P = 0.012; 0.009; 0.014). Prognostic analysis showed high B7-H4 expression was associated with significantly shorter OS. Multivariate analysis demonstrated the risk of death in CRC patients with high B7-H4 expression is 1.487 times that of low B7-H4 expression. In addition, B7-H4 expression was negatively correlated with the epithelial marker E-cadherin (P <  0.001) and positively correlated with the mesenchymal marker vimentin (P <  0.001) in CRC tissues. However, B7-H4 expression was not associated with the immunosuppressive microenvironment in CRC. CONCLUSION: B7-H4 may represent a potential biomarker for the diagnosis and prognosis of CRC and enhance CRC invasion by promoting EMT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10159-5. BioMed Central 2022-10-10 /pmc/articles/PMC9549643/ /pubmed/36217128 http://dx.doi.org/10.1186/s12885-022-10159-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yan, Xiaotian
Hong, Bo
Feng, Jie
Jin, Yuanqing
Chen, Mengting
Li, Fugang
Qian, Yun
B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition
title B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition
title_full B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition
title_fullStr B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition
title_full_unstemmed B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition
title_short B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition
title_sort b7-h4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549643/
https://www.ncbi.nlm.nih.gov/pubmed/36217128
http://dx.doi.org/10.1186/s12885-022-10159-5
work_keys_str_mv AT yanxiaotian b7h4isapotentialdiagnosticandprognosticbiomarkerincolorectalcancerandcorrelateswiththeepithelialmesenchymaltransition
AT hongbo b7h4isapotentialdiagnosticandprognosticbiomarkerincolorectalcancerandcorrelateswiththeepithelialmesenchymaltransition
AT fengjie b7h4isapotentialdiagnosticandprognosticbiomarkerincolorectalcancerandcorrelateswiththeepithelialmesenchymaltransition
AT jinyuanqing b7h4isapotentialdiagnosticandprognosticbiomarkerincolorectalcancerandcorrelateswiththeepithelialmesenchymaltransition
AT chenmengting b7h4isapotentialdiagnosticandprognosticbiomarkerincolorectalcancerandcorrelateswiththeepithelialmesenchymaltransition
AT lifugang b7h4isapotentialdiagnosticandprognosticbiomarkerincolorectalcancerandcorrelateswiththeepithelialmesenchymaltransition
AT qianyun b7h4isapotentialdiagnosticandprognosticbiomarkerincolorectalcancerandcorrelateswiththeepithelialmesenchymaltransition